Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 15
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP22F2569 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-02-10 | 2022-03-01 | 325412 | 8508862275!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2568 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-02-10 | 2022-03-01 | 325412 | 8508862272!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2119 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-01-18 | 2022-01-25 | 325412 | 8508811984!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2116 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-01-18 | 2022-01-25 | 325412 | 8508811867!ADENOVIRUS TYPE 4 A |
| SPE2DP22F2113 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $293.65K | 2022-01-18 | 2022-01-25 | 325412 | 8508811828!ADENOVIRUS TYPE 4 A |
| SPE2DP22F1329 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-12-07 | 2021-12-14 | 325412 | 8508730899!ADENOVIRUS TYPE 4 A |
| SPE2DP22F1328 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-12-07 | 2021-12-14 | 325412 | 8508730896!ADENOVIRUS TYPE 4 A |
| SPE2DP22F1326 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-12-07 | 2021-12-14 | 325412 | 8508730892!ADENOVIRUS TYPE 4 A |
| SPE2DP21F6148 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-09-09 | 2021-09-28 | 325412 | 8508509882!ADENOVIRUS TYPE 4 A |
| SPE2DP21F6147 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-09-09 | 2021-09-28 | 325412 | 8508509880!ADENOVIRUS TYPE 4 A |
| SPE2DP21F6142 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-09-09 | 2021-09-28 | 325412 | 8508509764!ADENOVIRUS TYPE 4 A |
| SPE2DP21F6138 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-09-09 | 2021-09-28 | 325412 | 8508509411!ADENOVIRUS TYPE 4 A |
| SPE2DP21F5504 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-08-11 | 2021-08-24 | 325412 | 8508433394!ADENOVIRUS TYPE 4 A |
| SPE2DP21F5503 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-08-11 | 2021-08-24 | 325412 | 8508433391!ADENOVIRUS TYPE 4 A |
| SPE2DP21F5501 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-08-11 | 2021-08-24 | 325412 | 8508433265!ADENOVIRUS TYPE 4 A |
| SPE2DP21F5488 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-08-11 | 2021-08-24 | 325412 | 8508432589!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4966 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-07-13 | 2021-07-20 | 325412 | 8508354400!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4965 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-07-13 | 2021-07-20 | 325412 | 8508354366!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4964 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-07-13 | 2021-07-20 | 325412 | 8508354365!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4300 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-06-08 | 2021-06-22 | 325412 | 8508275915!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4296 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-06-08 | 2021-06-22 | 325412 | 8508275804!ADENOVIRUS TYPE 4 A |
| SPE2DP21F4295 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-06-08 | 2021-06-22 | 325412 | 8508275803!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3777 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-05-06 | 2021-05-25 | 325412 | 8508191752!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3776 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-05-06 | 2021-05-25 | 325412 | 8508191719!ADENOVIRUS TYPE 4 A |
| SPE2DP21F3771 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $282.35K | 2021-05-06 | 2021-05-25 | 325412 | 8508191573!ADENOVIRUS TYPE 4 A |